Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Knowing when to rebalance your investment portfolio is crucial for success. Learn key timing insights to optimize your financial strategy.
20,317 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
The AI era has reshaped Palantir's role in enterprise data. This guide weighs the buy, sell, hold case for 2026 with ...
BITW fell 22.4% year-to-date through Feb. 25, 2026, tracking Bitcoin's drop and highlighting how diversification acro...
Long-running dividend growers are showing resilience as 2026 markets churn. AWR and NFG lead a small group with 50+ y...
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Investors are asking, 'honeywell stock just drop?' after a debt-reduction move. This guide explains what happened, wh...
Netflix and Meta are trading lower from recent highs, but their risk profiles differ. This piece weighs which merit a...
Geopolitical shocks can destabilize oil markets. This guide explains why midstream oil stocks often prove resilient d...
Investors are eyeing a possible SpaceX IPO, with a prospectus that analysts say could redefine how a private tech emp...
Investors are weighing Credo Technology Group after its latest earnings report. This article breaks down what the res...
Is GameStop stock a buy, hold, or sell in today’s market? This practical guide walks you through the current dynamics...
As markets shift and inflation cools, retirees at 60 face a critical question: how much monthly income can a $1.1 mil...